SecBot SecBot
SECBOTREPLAY Home › Report › MEDS

MEDS · ATM program up to $10M

DataMeds AI, Inc. · 424B5 filed Nov 16, 2026 at 06:22 ET

At the news

BEARISHIMPACT 5/10

424B5 filed Nov 16, 2026 at 06:22 ET

DataMeds AI filed a 424B5 prospectus supplement establishing an at-the-market (ATM) equity offering program of up to $10,003,649 in common stock, with Dawson James Securities as sales agent. The filing comes three days after the company reported Q3 2026 results showing a 50% sequential revenue increase but an 11.4% YoY revenue decline and a $3.4M operating loss, suggesting the capital raise is driven by ongoing cash needs.

  • ATM sales agreement with Dawson James Securities for up to $10,003,649 in common stock
  • 3.0% commission on gross proceeds to sales agent
  • 5,724,857 shares outstanding as of November 13, 2026
  • Maximum potential dilution: up to 13,518,445 shares at $0.74/share (236% of current shares outstanding)

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access